{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Investigational+Medicinal+Product+%28IR%29", "query": { "intervention": "Investigational Medicinal Product (IR)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 8, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T15:44:02.024Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04885530", "title": "ACTIV-6: COVID-19 Study of Repurposed Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Susanna Naggie, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 10956, "start_date": "2021-06-08", "completion_date": "2024-04-29", "has_results": true, "last_update_posted_date": "2025-11-17", "last_synced_at": "2026-09-29T15:44:02.024Z", "location_count": 110, "location_summary": "Chandler, Arizona • Gilbert, Arizona • Mesa, Arizona + 96 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04885530" }, { "nct_id": "NCT05081245", "title": "ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism Spectrum Disorder" ], "interventions": [ { "name": "ML-004 (IR)/(ER) tablet", "type": "DRUG" }, { "name": "ML-004 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MapLight Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 168, "start_date": "2022-09-13", "completion_date": "2026-04-17", "has_results": false, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-09-29T15:44:02.024Z", "location_count": 24, "location_summary": "Dothan, Alabama • Phoenix, Arizona • Glendale, California + 21 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Rafael", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05081245" }, { "nct_id": "NCT01332513", "title": "An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Investigational Medicinal Product (MR1)", "type": "DRUG" }, { "name": "Investigational Medicinal Product (MR2)", "type": "DRUG" }, { "name": "Investigational Medicinal Product (MR3)", "type": "DRUG" }, { "name": "Investigational Medicinal Product (MR4)", "type": "DRUG" }, { "name": "Investigational Medicinal Product (MR5)", "type": "DRUG" }, { "name": "Investigational Medicinal Product (IR)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 36, "start_date": "2011-02-10", "completion_date": "2011-05-23", "has_results": false, "last_update_posted_date": "2018-06-19", "last_synced_at": "2026-09-29T15:44:02.024Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01332513" }, { "nct_id": "NCT03670953", "title": "A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson's Disease (Disorder)" ], "interventions": [ { "name": "IR CD-LD", "type": "DRUG" }, { "name": "IPX203 ER CD-LD", "type": "DRUG" }, { "name": "Placebo Matching IPX203", "type": "OTHER" }, { "name": "Placebo Matching IR CD-LD", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Impax Laboratories, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 630, "start_date": "2018-11-06", "completion_date": "2021-06-15", "has_results": true, "last_update_posted_date": "2023-02-09", "last_synced_at": "2026-09-29T15:44:02.024Z", "location_count": 56, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Loma Linda, California + 46 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03670953" }, { "nct_id": "NCT01411137", "title": "Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "IPX066", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Impax Laboratories, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 43, "start_date": "2011-08", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2019-11-07", "last_synced_at": "2026-09-29T15:44:02.024Z", "location_count": 8, "location_summary": "Birmingham, Alabama • La Jolla, California • Sunnyvale, California + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Sunnyvale", "state": "California" }, { "city": "Ocala", "state": "Florida" }, { "city": "Bingham Farms", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01411137" }, { "nct_id": "NCT02768779", "title": "ARV Concentrations in Hair", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIV" ], "interventions": [ { "name": "Hair analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2016-04-01", "completion_date": "2017-01-30", "has_results": false, "last_update_posted_date": "2018-06-13", "last_synced_at": "2026-09-29T15:44:02.024Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02768779" }, { "nct_id": "NCT00869791", "title": "A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "IPX066", "type": "DRUG" }, { "name": "IR CD-LD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Impax Laboratories, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 27, "start_date": "2008-11", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2019-11-08", "last_synced_at": "2026-09-29T15:44:02.024Z", "location_count": 1, "location_summary": "Hayward, California", "locations": [ { "city": "Hayward", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00869791" }, { "nct_id": "NCT03935646", "title": "Acute Effects of Stimulant Medication in College Students With ADHD", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Attention Deficit Hyperactivity Disorder", "Stimulant Use", "Working Memory", "Change in Sustained Attention", "Mood" ], "interventions": [ { "name": "Adderall IR 10mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Wyoming", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "18 Years to 29 Years" }, "enrollment_count": 40, "start_date": "2020-02-11", "completion_date": "2025-06-30", "has_results": false, "last_update_posted_date": "2024-06-10", "last_synced_at": "2026-09-29T15:44:02.024Z", "location_count": 1, "location_summary": "Laramie, Wyoming", "locations": [ { "city": "Laramie", "state": "Wyoming" } ], "official_url": "https://clinicaltrials.gov/study/NCT03935646" } ] }